Literature DB >> 12396449

Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.

Ivona Pandrea1, David L Robertson, Richard Onanga, Feng Gao, Maria Makuwa, Paul Ngari, Issa Bedjabaga, Pierre Roques, François Simon, Cristian Apetrei.   

Abstract

Forty-one HIV-1 strains from Gabonese patients were studied according to the following strategy: nested polymerase chain reaction were performed to obtain an approximately 1,100-bp fragment containing the protease gene and the 5' half of the reverse transcriptase gene. Additional amplifications were carried out to obtain an approximately 700-bp fragment encompassing the C2V3 env gene. Fragments of 600 to 1,200 bp in the gag gene overlapping the pol sequences were used for the study of recombination patterns. Phylogenetic analyses of the different fragments were used to investigate HIV-1 diversity in Gabon. Thirty-one strains were sequenced in the env and pol genes and phylogenetic analyses classified them as subtype A (n = 2), D (n = 4), G (n = 1), H (n = 1), CRF02 (n = 8), and CRF MAL-like (n = 6); in addition, there were 6 unique recombinant forms and 1 unclassified strain, and in 2 cases pol/env sequences classified strains as subtype D whereas gag phylogeny classified them as subtype A. In 10 cases only 1 fragment was available: 4 env (2 subtype D, 1 subtype H, and 1 subtype U) and 6 pol (1 subtype A, 1 subtype C, 2 subtype G, and 2 subtype U). Minor mutations associated with viral resistance to antiretroviral drugs were observed in more than 80% of analyzed strains. Our study confirms the extensive HIV-1 diversity found in Central Africa, with more than 70% of strains from Gabon exhibiting discordant clustering in pol and env genomic regions and less than 60% concordance between sequencing and heteroduplex mobility assay genotyping. These findings highlight the fact that Central Africa represents the epicenter for the origin of HIV-1. The strategy of sequencing pol in association with env has proved to be useful for analysis of the recombinant strains. The main advantage of this approach is that it also allows for evaluation of genotypic susceptibility to antiretroviral drugs without the need for supplementary analyses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396449     DOI: 10.1089/088922202320567842

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.

Authors:  Philip L Bulterys; Sudeb C Dalai; David A Katzenstein
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.

Authors:  Diane L Hirigoyen; Charles P Cartwright
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm.

Authors:  Cristian Apetrei; Amitinder Kaur; Nicholas W Lerche; Michael Metzger; Ivona Pandrea; Johnny Hardcastle; Shelley Falkenstein; Rudolf Bohm; Jeffrey Koehler; Vicki Traina-Dorge; Tessa Williams; Silvija Staprans; Gail Plauche; Ronald S Veazey; Harold McClure; Andrew A Lackner; Bobby Gormus; David L Robertson; Preston A Marx
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.

Authors:  Nuno R Faria; Marc A Suchard; Ana Abecasis; João D Sousa; Nicaise Ndembi; Idalina Bonfim; Ricardo J Camacho; Anne-Mieke Vandamme; Philippe Lemey
Journal:  Infect Genet Evol       Date:  2011-05-04       Impact factor: 3.342

5.  Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.

Authors:  Ivona Pandrea; Christopher Kornfeld; Mickael J-Y Ploquin; Cristian Apetrei; Abdourahmane Faye; Pierre Rouquet; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin; Ousmane M Diop
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Transmitted drug resistance in nonsubtype B HIV-1 infection.

Authors:  Philip A Chan; Rami Kantor
Journal:  HIV Ther       Date:  2009-09-01

Review 7.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

8.  HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations.

Authors:  Nuno R Faria; Andrew Rambaut; Marc A Suchard; Guy Baele; Trevor Bedford; Melissa J Ward; Andrew J Tatem; João D Sousa; Nimalan Arinaminpathy; Jacques Pépin; David Posada; Martine Peeters; Oliver G Pybus; Philippe Lemey
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

9.  Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa.

Authors:  Mélanie Caron; Sonia Etenna Lekana-Douki; Maria Makuwa; Guy-Patrick Obiang-Ndong; Olivia Biba; Dieudonné Nkoghé; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2012-03-20       Impact factor: 3.090

10.  Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa.

Authors:  Edson Delatorre; Daiana Mir; Gonzalo Bello
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.